Although signaling elicited by the stem cell factors SOX2, OCT4, KLF4, and MYC has been associated with cancer progression in several tumors, it has remained unclear how these signaling molecules mediate bladder cancer progression. The gene discussed is SOX2; the disease is urinary bladder carcinoma.